Skip to content

Clinical trials

Terminated Leukemia, Lymphocytic, Chronic, B-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Terminated Country / region: United States Clear all

284 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
200110
20022
20032
200414
200516
200615
200710
200825
200913
201022
20119
201213
201312
201411
201514
201613
20179
201810
201910
202013
202110
20229
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated284

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)32
Gilead Sciences18
M.D. Anderson Cancer Center18
Masonic Cancer Center, University of Minnesota12
TG Therapeutics, Inc.10
Fred Hutchinson Cancer Center7
OHSU Knight Cancer Institute6
City of Hope Medical Center5
Biogen4
Case Comprehensive Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell284
Lymphoma, Non-Hodgkin120
Lymphoma, Follicular110
Lymphoma, Mantle-Cell101
Precursor Cell Lymphoblastic Leukemia-Lymphoma99
Lymphoma, Large B-Cell, Diffuse96
Lymphoma, B-Cell, Marginal Zone93
Lymphoma77
Leukemia76
Hodgkin Disease69

Trials

Showing 1 to 25 of 284. Each trial links to its page on Pharma Observatory.

184 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.